neutralizing antibodies derived b cells influenza pandemic survivors
investigation human antibody response influenza virus infection largely limited serology relatively little analysis molecular level h1n1 influenza virus pandemic severe modern era recent work recovered gene sequences unusual strain pandemic virus reconstituted display unique virulence phenotypes however little known adaptive immunity virus took advantage virus sequencing resultant production recombinant haemagglutinin ha protein antigen characterize clonal level neutralizing antibodies induced natural exposure survivors pandemic virus show individuals tested born showed seroreactivity virus nearly years pandemic seven eight donor samples tested circulating b cells secreted antibodies bound ha isolated b cells subjects generated five monoclonal antibodies showed potent neutralizing activity virus three separate donors antibodies also cross reacted genetically similar ha swine h1n1 influenza strain cross react contemporary human influenza viruses antibody genes unusually high degree somatic mutation antibodies bound ha protein high affinity exceptional virus neutralizing potency protected mice lethal infection isolation viruses escaped inhibition suggested antibodies recognize classical antigenic sites ha surface thus studies demonstrate survivors influenza pandemic possess highly functional virus neutralizing antibodies uniquely virulent virus humans can sustain circulating b memory cells viruses many decades exposure well tenth decade life
